Source · Select Committees · Public Accounts Committee
Recommendation 6
6
For the next few years it is likely that waiting time performance for cancer and...
Recommendation
For the next few years it is likely that waiting time performance for cancer and elective care will remain poor and the waiting list for elective care will continue to grow. The UK has low numbers of healthcare resources per person compared with similar countries and actions taken now to increase its resources will likely take years to be realised. We are concerned that officials are too optimistic about the resilience of NHS services in the short- and medium-term, particularly as NHS staff have been working under continuously high pressure during the pandemic and the system is yet to feel the full effect of missing cancer and elective patients returning for care. The National Audit Office estimates that the elective care waiting list might grow to around 7 million people by March 2025, compared with 6.075 million in December 2021, even if the NHS manages to increase elective activity to its stated aim of 30% above pre-pandemic levels. Recommendation: The Department and NHSE&I must be realistic and transparent about what the NHS can achieve with the resources it has and the trade-offs that are needed to reduce waiting lists. In implementing its elective recovery plan, NHSE&I should set out clearly what patients can realistically expect in terms of waiting times for elective and cancer treatment. By the time of the next Spending Review at the latest, the Department and NHSE&I should have a fully costed plan to enable legally binding elective and cancer care performance standards to be met once more. 8 NHS backlogs and waiting times in England 1 Accountability and planning
Government Response
Not Addressed
HM Government
Not Addressed
6.1 The government agrees with the Committee’s recommendation. Target implementation date: Spring 2023 6.2 The government has been clear that the overall NHS waiting list is likely to worsen prior to improvements and service recovery. 6.3 As set out in the response to recommendation 2, NHS England also published the Elective Recovery Plan in February 2022. This plan sets out a clear vision for how the NHS will recover and expand elective and cancer services over the next three years, and what patients can expect. There are also clear goals and objectives set on prioritisation within the Recovery Plan. This allows better understanding of future demand, with further updates to be provided later in the year. 6.4 All of the above however, is subject to demand and capacity levels similar to pre-covid, whilst also maintaining low levels of Covid across the NHS. 6.5 The government agrees with the Committee’s recommendation. Target implementation date: Autumn 2024 6.6 The Elective Recovery Plan sets out goals for this Spending Review period to use the current funding settlement to maximise elective performance. 6.7 However, as referenced in the response to recommendation 2, there remains both short-term and long-term uncertainty around capacity and demand because of the pandemic and its impact. Ahead of the next Spending Review settlement process, the department will work closely with NHSE&I and other stakeholders to develop funding proposals for the next SR period to be submitted to HM Treasury, using the latest data available at the time.